Schonfeld Strategic Advisors’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.47M | Sell |
909,640
-681,416
| -43% | -$1.85M | 0.02% | 790 |
|
|
2025
Q1 | $3.58M | Buy |
1,591,056
+1,097,156
| +222% | +$2.47M | 0.02% | 571 |
|
|
2024
Q4 | $1.73M | Buy |
+493,900
| New | +$1.73M | 0.01% | 836 |
|
|
2024
Q1 | – | Sell |
-50,100
| Closed | -$116K | – | 2071 |
|
|
2023
Q4 | $116K | Sell |
50,100
-80,500
| -62% | -$186K | ﹤0.01% | 1513 |
|
|
2023
Q3 | $168K | Buy |
130,600
+100
| +0.1% | +$129 | ﹤0.01% | 1310 |
|
|
2023
Q2 | $172K | Sell |
130,500
-30,100
| -19% | -$39.7K | ﹤0.01% | 1541 |
|
|
2023
Q1 | $114K | Buy |
160,600
+4,600
| +3% | +$3.25K | ﹤0.01% | 1623 |
|
|
2022
Q4 | $117K | Buy |
156,000
+4,600
| +3% | +$3.45K | ﹤0.01% | 2108 |
|
|
2022
Q3 | $130K | Sell |
151,400
-564,296
| -79% | -$485K | ﹤0.01% | 2433 |
|
|
2022
Q2 | $802K | Sell |
715,696
-163,427
| -19% | -$183K | 0.01% | 1048 |
|
|
2022
Q1 | $984K | Buy |
879,123
+158,330
| +22% | +$177K | 0.01% | 943 |
|
|
2021
Q4 | $1.15M | Sell |
720,793
-100,000
| -12% | -$160K | 0.01% | 807 |
|
|
2021
Q3 | $1.99M | Sell |
820,793
-504,260
| -38% | -$1.22M | 0.02% | 658 |
|
|
2021
Q2 | $4.2M | Buy |
1,325,053
+52,000
| +4% | +$165K | 0.04% | 480 |
|
|
2021
Q1 | $4.29M | Buy |
1,273,053
+115,053
| +10% | +$388K | 0.05% | 437 |
|
|
2020
Q4 | $4.15M | Buy |
1,158,000
+814,805
| +237% | +$2.92M | 0.06% | 415 |
|
|
2020
Q3 | $899K | Buy |
+343,195
| New | +$899K | 0.02% | 689 |
|